ALZN: Alzamend Neuro, Inc. Stock

by  •  • Comments Off on ALZN: Alzamend Neuro, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.87
Enterprise Value ($M) 4.99
Book Value ($M) -3.79
Book Value / Share -0.55
Price / Book -1.29
NCAV ($M) -3.98
NCAV / Share -0.58
Price / NCAV -1.23

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.46
Return on Equity (ROE) -2.12

Liquidity (mrq)
Quick Ratio 0.16
Current Ratio 0.16

Balance Sheet (mrq) ($M)
Current Assets 0.59
Assets 0.78
Liabilities 4.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-02 13D/A Ault Milton C Iii 40.30 62.95

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-12-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-09-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-07-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended April 30, 2023 o TRANSITION REPORT PURSUANT TO SECTION

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 4,483 25,144 17.83
2024-04-24 6,288 18,698 33.63
2024-04-23 2,100 18,672 11.25
2024-04-22 13,945 3,953 352.77

(click for more detail)

Similar Companies
ALDX – Aldeyra Therapeutics, Inc. ALGS – Aligos Therapeutics, Inc.
ALRN – Aileron Therapeutics, Inc. ANEB – Anebulo Pharmaceuticals, Inc.
ANIX – Anixa Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io